Mirtazapine-Associated Blood Pressure Effects
Mirtazapine can be associated with orthostatic hypotension, particularly early after initiation. [1] Mirtazapine can also be associated with hypertension as an adverse reaction in clinical trial adverse-event listings. [1]
Orthostatic Hypotension
Mirtazapine was associated with “significant orthostatic hypotension” in early clinical pharmacology trials in normal volunteers. [1] Orthostatic hypotension was infrequently observed in clinical trials in patients with depression. [1] A review of antidepressant effects on blood pressure describes mirtazapine as having minimal effects on blood pressure while noting that orthostatic hypotension and falls may occur rarely. [2]
Hypertension
Mirtazapine adverse reactions include hypertension in the cardiovascular system adverse-event listing. [1] A review of antidepressant drugs and blood pressure notes that antidepressants as a class can induce hypotension and orthostatic hypotension, with hypertension occurring in some contexts, including via drug-specific effects or patient-specific factors. [2]
Clinical Monitoring Considerations
Orthostatic blood pressure should be assessed when dizziness, syncope, falls, or postural symptoms occur during treatment. [1] Caution is recommended in patients with cardiovascular or cerebrovascular disease that could be exacerbated by hypotension. [1] Caution is recommended in patients predisposed to hypotension, including those with dehydration or hypovolemia or those taking antihypertensive medications. [1]
Initiation and Risk Timing
Orthostatic hypotension risk is emphasized in early clinical pharmacology trials, supporting heightened vigilance around treatment initiation and dose changes. [1] Orthostatic hypotension was infrequently observed across depressive disorder clinical trials. [1]
Management of Suspected Drug-Related Blood Pressure Change
Mirtazapine should be reconsidered when clinically significant orthostatic hypotension, syncope, or falls occur during treatment. [1] Concomitant antihypertensive therapy and volume status should be reviewed when hypotension develops during treatment. [1]
Common Pitfalls to Avoid
Attribution of dizziness or near-syncope solely to psychiatric symptoms can delay recognition of orthostatic hypotension. [1] Overlooking volume depletion or concurrent antihypertensive therapy can increase risk of hypotension-related events during mirtazapine treatment. [1]
Practical Summary for Prescribing
Mirtazapine is associated with orthostatic hypotension risk, with infrequent observation in depression trials and evidence of significant effects in early volunteer pharmacology studies. [1] Mirtazapine is also associated with hypertension as an adverse reaction in clinical trial adverse-event listings, although hypertension is not the dominant labeled hemodynamic effect. [1]